Zai Lab (ZLAB) Other Non Operating Income (2020 - 2026)
Zai Lab's (ZLAB) quarterly Other Non Operating Income came in at $14.8 million in Q1 2026, up 7631.47% year-on-year from $191903.9 in Q1 2025, and down 10.33% quarter-over-quarter from $16.5 million in Q4 2025.
Zai Lab (ZLAB) Other Non Operating Income (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Other Non Operating Income across 7 years of filings, most recently posting $14.8 million for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $14.8 million, up 7631.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.6 million (up 242.6% YoY), and the FY2025 annual result was $19.6 million, up 229.42% from the prior year.
- Other Non Operating Income came in at $14.8 million for Q1 2026 at Zai Lab, down from $16.5 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $16.5 million in Q4 2025 to a low of -$50.0 million in Q4 2022.
- The 5-year median for Other Non Operating Income is -$197000.0 (2025), against an average of -$5.9 million.
- Across the five-year window, Other Non Operating Income slumped 571.17% in 2022 and soared 7631.47% in 2026, its largest moves.
- Zai Lab's Other Non Operating Income stood at -$50.0 million in 2022, then soared by 113.57% to $6.8 million in 2023, then sank by 445.25% to -$23.4 million in 2024, then soared by 170.66% to $16.5 million in 2025, then declined by 10.33% to $14.8 million in 2026.
- The last three Other Non Operating Income figures came in at $14.8 million (Q1 2026), $16.5 million (Q4 2025), and -$508000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.84 Mn |
| Dec 31, 2025 | 16.55 Mn |
| Sep 30, 2025 | -508,000.00 |
| Jun 30, 2025 | 3.75 Mn |
| Mar 31, 2025 | -197,000.00 |
| Dec 31, 2024 | -23.42 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | -4.11 Mn |
| Mar 31, 2024 | -2.07 Mn |
| Dec 31, 2023 | 6.78 Mn |
| Sep 30, 2023 | 394,000.00 |
| Jun 30, 2023 | -1.41 Mn |
| Mar 31, 2023 | 8.91 Mn |
| Dec 31, 2022 | -49.99 Mn |
| Sep 30, 2022 | -40.44 Mn |
| Jun 30, 2022 | -34.90 Mn |
| Mar 31, 2022 | 2.29 Mn |
| Dec 31, 2021 | 17.06 Mn |
| Sep 30, 2021 | -13.58 Mn |
| Jun 30, 2021 | 7.41 Mn |